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PregnancyIntroduction
Cervical cancer is the most frequent oncologic pathology discovered
during pregnancy and is considered particularly challenging, as the care
of the patient involves the survival of the patient as well as the viability
and well-being of the fetus. Currently, there is no consensus regarding
the most effective treatment for cervical cancer during pregnancy due
to the rarity of its occurrence. In 2008, Van de Nieuwenhof (Van de
Nieuwenhof et al., 2008) reported the ﬁrst successful case of radical
vaginal trachelectomy (RVT) and abdominal pelvic lymphadenectomy
in a patient who was 16 weeks pregnant and gave birth after 36 weeks
gestation. In 2006, Ungar (Ungar et al., 2006a) published the ﬁrst case
of radical abdominal trachelectomy (RAT), which was also considered
successful. The present report describes the ﬁrst RVT with laparoscopic
pelvic lymphadenectomy that occurred in June 2008, in a patient who
was 11 weeks pregnantwhen shewas diagnosedwith stage IB1 cervical
cancer. The procedurewas considered successful, as the fetus completed
its development in utero, and both the patient and child remained
healthy throughout the length of the follow-up.
Case study
A 41 year-old patient, G3P2, without previous morbidity com-
plained of vaginal bleeding during the ﬁrst trimester of her pregnancy.⁎ Corresponding author at: La Coruña 1526, Viña del Mar, Chile.
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ease, a biopsy of the exocervix was made, and a non-keratinizing squa-
mous cell cervical carcinoma was diagnosed. The lesion was clinically
labeled as a FIGO stage IB1 tumor by the gynecooncologic committee
of the hospital. The tumor resided on the cervix, which was 3 cm in
length, and did not demonstrate parametrial compromise. In line with
patient's wish to preserve the pregnancy, the case was thoroughly dis-
cussed and several treatment options were offered to the patient and
her husband including radical hysterectomy, radiochemotherapy, and
a delay in treatment until fetalmaturity. Eventually RVTwith systematic
laparoscopic pelvic lymphadenectomy (SLPL) was proposed as an ex-
perimental procedure that would allow treatment of the cancer while
preserving the pregnancy. Fully informed of the risks, the patient
opted for RVT with SLPL and signed an informed consent form that
was speciﬁcallywritten for this case. To prevent the induction of prema-
ture labor, the patient was administered a daily dose of 200 mg of intra-
vaginal micronized progesterone throughout the entire pregnancy and
no antibiotics were administered.
The surgical interventionoccurred in June2008, andbegunwith a suc-
cessful SLPLwithout suspicion of nodularmetastasis upon gross examina-
tion. Subsequently in a trans-vaginal manner, the RVTwas performed to
remove a 2 cmvaginal cuff. The surgical removal of the vaginal cuff left a
0.5 cm cervical remnant to which a PROLENE cerclage was surgically
implanted. The vaginawas sutured to the cervical stumpusing Vicryl su-
tures. The total blood loss was estimated to be approximately 300 cc.
There were no complications during or after surgery, which lasted ap-
proximately 300 min. The patientwas discharged 7 days after theproce-
dure and was monitored in the High-risk Obstetric and Oncologic
Gynecology Unit every 3 weeks. Monitoring revealed no signs of recur-
rence; moreover, the fetus developed normally and showed no symp-
toms indicating a premature birth.
A deﬁnitive biopsy was evaluated by a pathologist, who reported a
35×30×30 mm exophytic tumor corresponding to a non-keratinized
squamous cell cervical carcinoma with grade III cervical intraepithelial
neoplasia. The margins were negative at the base and there was mini-
mal stromal inﬁltration. The lymphatic vessels were not compromised.
The section edges and the parametrium were tumor-free, and the 22
lymph nodes that were collected showed no signs of metastasis.
After 36 weeks of gestation a Cesarean-hysterectomywas performed,
and a 46 cm long, healthymale newbornwas deliveredweighing 2790 g.
Apgar test results 1 min after delivery and 5 min after delivery were 5
and 7, respectively. Biopsy of the cervical tissue following the SVT
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Postoperative Computed Axial Tomography was negative for metasta-
sis. After consulting with the oncologic committee, the patient and the
committee mutually agreed not to pursue further treatment, and peri-
odic check-ups and supervision were recommended. Forty months
after the initial SVT surgery, both the patient and her child were healthy
and displayed no signs of pathology.
Discussion
Overall, 15% of cervical cancers and 45% of stage IB cervical cancers
in women under 40 years of age are treated by surgery. A signiﬁcant
number of these patients are fertile when the diagnosis is made and
thus can beneﬁt from surgical techniques that enable them to pre-
serve their reproductive capacity (Covens et al., 2001). Cervical can-
cer is the most frequently diagnosed cancer in pregnant women,
affecting between 1 and 10 in 10,000 pregnant women (Duggan et
al., 1993).
The most effective treatment for cervical cancer during pregnancy
is not well deﬁned and depends on several factors, such as gestational
age of the fetus, stage of the disease and the patient's desire to pre-
serve the pregnancy. Because of the rarity of cervical cancer occurring
during pregnancy, most treatment options are still considered experi-
mental. The literature that exists on treating cervical cancer during
pregnancy describes three treatment options for women who wish to
preserve their pregnancy: 1) scheduled delay of treatment until
fetal viability is reached (Traen et al., 2006), 2) neoadjuvant chemo-
therapy until fetal viability is reached followed by a Cesarean hysterec-
tomy (Bader et al., 2007) and 3) radical trachelectomy (Ungar et al.,
2006b). It remains unclear whether the prognosis of cervical cancer is
inﬂuenced by the pregnancy; however, there is a consensus that delay-
ing oncological intervention is an acceptable alternative for pregnant
womanwho are at the end of their second trimester or in their third tri-
mester. Delaying treatment in these patients presents a 5% risk of recur-
rence, which is similar to the rate of recurrence in women who are not
pregnant. Neoadjuvant chemotherapy is used to reduce the size of the
tumor and to prevent lymphatic metastasis. To date 9 cases of pregnant
women treated for cervical cancer with neoadjuvant chemotherapy
have been reported, of which 2 have passed away, and all have had
good perinatal results. Chemotherapy is based on a platinum derivative
drug used in combination with another agent; this chemotherapy regi-
men is contraindicated during the ﬁrst trimester due to the associated
risks for miscarriage, fetal death and minor fetal malformations.
In 1994, Dargent described the initial a RVT following a laparo-
scopic pelvic lymphadenectomy, removing a major part of the cervix,
the parametrium and the vaginal cuff in the process. Several subse-
quent publications have reproduced this technique with promising
oncological and perinatological results (Dargent et al., 2000; Shepherd
et al., 1998). This technique has been successfully performed in patients
with early-stage cervical cancer achieving a 2-year survival rate of ap-
proximately 97% and strongly encouraging its use in pregnant patients
with cervical cancer.
In 2006, Ungar published 5 cases of radical abdominal trachelectomy
with pelvic lymphadenectomy in pregnant patients between 7 and
18 weeks gestation with good oncological results; no recurrences
were observed in any of the patients during the 40 months of moni-toring following the procedure. However, 3 of those 5 patients had a
miscarriage immediately after surgery, while the other 2 patients
were able to complete the gestational period (Ungar et al., 2006a).
In 2004, Ben-Arie described a more conservative management of a
patient with a 15-week pregnancy and a poorly differentiated stage
Ia2 cervical tumor. In this procedure, a cold knife cone dissectionwas per-
formed resulting in negative margins, followed by node-negative extra-
peritoneal pelvic lymphadenectomy. The pregnancy lasted 39 weeks, at
which point a C-section was performed. An RVT was performed
6 weeks after delivery. Both mother and son are currently healthy after
3 years of monitoring (Ben-Arie et al., 2004).
Finally, in 2008, Van de Nieuwenhof published the ﬁrst case of RVT
with an abdominal pelvic lymphadenectomy and cerclage in a patient
with a 16-week pregnancy. The patient underwent, a Cesarean-
hysterectomy at 36 weeks gestation, and the patient and child were
healthy 9 months after the delivery (Van de Nieuwenhof et al., 2008).
The case reported in this document is the ﬁrst report in which the
lymphadenectomywas performed by laparoscopic means. Laparoscopy
has the advantage of requiring very littlemanipulation of the uterus and
diminishes the possibility of miscarriage following the procedure while
maintaining the ability to harvest all of the implicated pelvic lymph
nodes. Vaginal trachelectomy is advantageous in that it prevents exces-
sive bleeding as also described in abdominal techniques. In summary,
this case study is the ﬁrst to report the use of laparoscopy with radical
vaginal trachelectomy in a patient who was 11 weeks pregnant with
IB1 cervical cancer andwishes to preserve her pregnancy. Asmentioned
earlier, the advantages of this technique include minimal manipulation
of the uterus and a rapid recovery with good oncological and perinato-
logical results.
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